Moclobemide and Selegeline in the Treatment of Depression in Parkinson's Disease

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.63.4.547
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Depression in Parkinson's Disease

Nevrologiya, Neiropsikhiatriya, Psikhosomatika
PsychiatryClinical PsychologyMental HealthNeurology
2010English

Potential Mechanisms Underlying Anxiety and Depression in Parkinson's Disease: Consequences of L-Dopa Treatment

Neuroscience and Biobehavioral Reviews
Physiological PsychologyNeuropsychologyBehavioral NeuroscienceCognitive Neuroscience
2011English

Parkinson's Disease and Depression: Psychometric Properties of the Beck Depression Inventory.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1988English

Depression in Patients With Parkinson's Disease With Dementia

SANAMED
2017English

Bromocriptine Treatment in Parkinson's Disease.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1976English

Management of Depression in Parkinson's Disease: A Systematic Review

Movement Disorders Clinical Practice
Neurology
2017English

The Impact of Treatment of Depression on Quality of Life, Disability and Relapse in Patients With Parkinson's Disease

Movement Disorders
Neurology
2009English

Treatment of Parkinson's Disease

New England Journal of Medicine
Medicine
1994English

Treatment of Parkinson's Disease

New England Journal of Medicine
Medicine
1961English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy